CoChat

Testosterone increases bone mineral density in female‐to‐male transsexuals: a case series of 15 subjects

Open access
Turner, Adrian, Chen, Tai C., Barber, Tom W., Malabanan, Alan O., Holick, Michael F., Tangpricha, Vin · 2004 · Clinical Endocrinology
Cited by 83

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Summary: objective Testosterone therapy for osteoporosis has not been studied extensively in women because of its potential to cause virilization. Female‐to‐male transsexuals are genetic females who suffer from gender dysphoria and thus take supra‐physiologic doses of testosterone to change from the female to male phenotype. The aim of this study is to examine the effects of testosterone treatment on the genetic female skeleton. patients and design A group of 15 female‐to‐male transsexuals was prospectively enrolled for observation over a 2‐year period. The subjects had a mean age of 37·0 ± 3·0 years. All of the subjects self‐administered testosterone esters intramuscularly at a mean dose of 70·7 ± 4·5 mg weekly. measurements The subjects had measurements of bone mineral density (BMD) by dual X‐ray absorptiometry (DXA) of the femoral neck and spine (L2–L4) at 12‐month intervals. They had determinations of serum oestradiol, testosterone, soluble RANKL (sRANKL), osteoprotegerin (OPG) and urine N‐telopeptide (NTX) at the date of enrolment and at the end of 2 years. results There was a significant positive increase in mean BMD of 7·8% at the femoral neck and a nonsignificant increase in mean BMD of 3·1% at the spine over 2 years. The levels of testosterone reached the upper normal range for males and the levels of oestradiol declined to near the postmenopausal range. sRANKL levels decreased significantly in female‐to‐male transsexuals who newly initiated testosterone therapy. There was no significant change in urine NTX or serum OPG during the study. conclusions We conclude that supra‐physiologic testosterone therapy increases BMD at the hip while maintaining BMD at the spine in female‐to‐male transsexuals. The effects of testosterone may be the result of testosterone hormone directly acting on the bone or indirectly through aromatization to oestradiol. Lower RANKL levels coupled with unchanged OPG levels results in an increased OPG/RANKL ratio, which may be beneficial to the bone by inhibiting osteoclastogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2004.02125.x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 83

Metadata

Authors
Turner, A., Chen, T. C., Barber, T. W., Malabanan, A. O., Holick, M. F., & Tangpricha, V.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2004-10-12
Volume
61
Issue
5
Pages
560-566
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2004105591
Cited by
83
References
13
FWCI
2.79
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.